Quality Of Life In Hypertension Research Articles

Quality of Life in Hypertensive Teachers of regular basic education who go to an Establishment during the health Emergency due to COVID-19 in North Lima

The quality of life in hypertensive teachers of regular basic education is one of the priorities committed to health well-being, since it will depend on how the person can minimize the risks due to this disease, so the research objective is to determine the quality of life in hypertensive teachers of regular basic education who come to an establishment during the health emergency due to COVID-19 in North Lima. It is a quantitative, descriptive-transverse study, consisting of a population of 131 hypertensive teachers of regular basic education who answered a questionnaire on sociodemographic aspects and the questionnaire on quality of life in hypertension. In their results we can observe that 64,1 % (n=84) of hypertensive teachers of regular basic education have a good quality of life, 9,2 % (n=12) regular quality of life and 26,7 % (n=35) poor quality of life. In conclusion, strategies should be made to promote and prevent hypertension, and thus allow the population the necessary information about the disease and how to counteract it.

Assessment of quality of life for hypertensive patients: Integrative review for Potential of Novel Assessment Tools of quality of life

Background & Aim: The body of literature on QoL has steadily grown over recent years, spurred by the promotion of research and the cross-cultural adaptation and validation of assessment instruments in different languages. However, limited information exists on the most commonly used instruments against the backdrop of current demographic and epidemiological trends. The aim this study to evaluate QoL assessment instruments used in hypertensive patients. Methods & Materials: This review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Databases used including Sciencedirect, Cochrane library, Pubmed, Proquest, and the Wiley Online Library, utilizing keywords that are tailored to the Mesh Terms. Systolic Blood Pressure (SBP) value at least 140 mmHg and/or Diastolic Blood Pressure (DBP) value at least 90 mmHg, or the patient had a history of hypertension and was administered with antihypertensive drugs, English version, observational studies that presented Health-Related Quality of Life (HRQoL) scores in hypertensive individuals using varied assessment tools (WHOQoL BREF, SF-36, MINICHAL, etc) where these tools assess the situation of the patient’s quality of life based on the domain of life (physiological, psychological, social interaction, etc.) in the form of numbers, and published between January 2000 to December 2021 were inclusion criteria of the study. Relevant studies were read critically, analyzed, and described in detail. Survey data were processed in the form of comparative tables. Results: A total of 2,287,348 references were found through databases, and for the final screening, twenty-two articles were finally designated as articles to be reviewed. The SF-36 (SF-8, SF-12), WHOQoL BREF, MINICHAL, and PECVEC are assessment tools used in the studies included in this review. The SF-36 was the most widely used tool in the studies included in this review. One of the critical domains to assess is spiritual, where none of the studies included this domain. Conclusion: The SF-36 is the most frequently used assessment tool. However, this form is a general form that is not explicitly intended to assess the quality of life in hypertension only. The spiritual domain is one of the important items that need to be included in the QoL assessment tool.

The impact of antihypertensive treatment initiation on health-related quality of life and cardiovascular risk factor levels: a prospective, interventional study

BackgroundEffective prevention and treatment of hypertension is one of the most potential interventions in terms of preventing cardiovascular deaths and disabilities. However, the treatment control is often poor. This may be partly explained by the impact of hypertension diagnoses and treatment on health-related quality of life. Quality of life is also an important outcome for a hypertensive patient. Most of the previous studies on health-related quality of life in hypertension have concentrated on patients with treated hypertension and less is known about the initiation of medication and the first treatment year.MethodsIn this interventional study, we followed 111 primary care patients with newly diagnosed hypertension in real world primary care setting in Finland for 12 months.ResultsWe found significant decrease in both systolic and diastolic blood pressure levels, as well as modest decrease in cholesterol levels and alcohol consumption. However, the health-related quality of life also slightly deteriorated during the first treatment year.ConclusionsOur study shows that the initiation of hypertension treatment results in cardiovascular risk decrease among newly diagnosed Finnish hypertensive patients, but it is accompanied by small negative impact on health-related quality of life. However, the deterioration in health-related quality of life is of small magnitude and earlier research demonstrates several measures to enhance treatment and avoid impairment in health-related quality of life.Trial registration ClinicalTrials NCT02377960 (Date of registration: 04/03/2015).

Effect of Home Based Yoga on Blood Pressure and Quality of Life in Patients with Hypertension

Background and Aim: Hypertension is one of the major growing global problems. Management of hypertension by medicine, diet and exercise is not enough and alternative therapy is need of time. Yoga is one such substitute healthcare practice assumed to improve blood pressure control and quality of life in hypertensive. A prospective intervention was designed to check the effect of home based yoga exercise on blood pressure and quality of life in hypertensives. Methods: A total 74 hypertensive participants were recruited for the present study after following inclusion and exclusion criteria. Participants were divided into two groups, study group (n=39) who have done home based yoga and control group (n=35) who have not done home based yoga. Detailed methodology of home based yoga; their advantage and disadvantage were explained to the study group very well. Study group have done their home based yoga for three months and control group did not have done the home based yoga. Cardiovascular parameters like systolic blood pressure, diastolic blood pressure and pulse rate were recorded after following all standard precautions at the time of initiation of study and at end of every month till completion of study. Participants were also assessed for their quality of life, health and other areas of life by World Health Organization Quality of Life questionnaire at the time of beginning of the study and at every month till completion of study. Results: Significant decrease in systolic blood pressure from 130.60 ± 4.06 to 124.20 ± 0.60 mm of Hg and diastolic blood pressure from 85.62 ± 5.55 to 79.21 ± 0.73 mm of Hg were seen in study group. In control group, blood pressure reduction was not seen. Self rated score of quality of life was improved in study group as compared to control group. Conclusion: A short term home-based yoga program in hypertensive patients have shown to reduce blood pressure as well as positive effect on self-rated quality of life compared to controls. A simple 12-weeks duration home based yoga exercise program may be useful as supplementary therapy in addition to antihypertensive drugs in hypertensive patients.

Assessment of Quality of Life in Diabetes and Hypertensive Patients Attending Tertiary Care Hospitals in Khammam Region

Abstract: Background: Majority of people with chronic diseases especially having Hypertension and Diabetes have poor Quality Of Life to their therapeutic regimen and life style. It can also result in a variety of complications in body systems associated with undesirable metabolic conditions which affects the quality of life. Objectives: To inquire the effect of satisfaction of Hypertension by exploring Quality Of life in Hypertension and Diabetes. Methodology: A prospective cross sectional study was conducted for six months at tertiary care hospital, Khammam, Telangana. Sample of 200 patients were consented and interviewed to collect the information with an agreement to participate on the subject of socio demographics, physical, mental and behavioral characteristics using a structured questionnaire. Quality Of Life is measured by MINICHAL scale which contains two domains specifically mental domain and somatic domain with 17 questions. It as four potential answers, by way of the scores of 0=not at all, 1=yes, somewhat, 2=yes, a lot, 3=yes very much and sum the points ranging on or after 0-51 International Diabetes Federation indicates the best and worst levels of health, whereas last question be a sign of the overall agreement to participate the patient in study. Results: The scrutiny of this current study found that there is an average quality of life around 61.4% in hypertension and 44.4% in hypertension and diabetes. A significant correlation was also established by using chi square test, the p value is <0.001. Conclusion: This learning show, self-care is required to avoid the disease and as historical statements further more counselling is needed in patients to get better Quality Of Life. Key words: Chronic diseases, Hypertension, Diabetes, Quality of life, Mental domain, Somatic domain, MINICHAL, Significant Correlation.

Isometric handgrip training does not improve quality of life in hypertensives

Hypertensive patients have high blood pressure and poor cardiovascular health and it is known that hypertension negatively affects people's health-related quality of life. Meta-analyses have shown that isometric handgrip training (IHT) reduces blood pressure in hypertensives, but the effects of IHT on health-related quality of life is unknown. Therefore, we tested the hypotheses that the IHT improves health-related quality of life in hypertensives. In this randomized controlled trial, 48 hypertensive individuals were randomly assigned to two groups: IHT and control. IHT was completed thrice weekly (4 × 2 min at 30% of maximal voluntary contraction). Before and after 12 weeks health-related quality of life was assessment through Medical Outcomes Study Questionnaire Short Form 36 (SF36). No signi?cant effect was observed for physical function (IHT: 85.6±4.6 vs. 81.1±7.2; Control: 78.6±76.7±4.9), physical problems (IHT: 71.4±10.1vs. 83.9±8.1; Control: 73.8±8.2 vs. 64.3±8.0), general health (IHT: 56.1±3.7 vs. 57.1±1.9; Control: 54.3±1.6 vs. 57.6±2.1), pain (IHT: 23.6±4.6 vs. 30.7±5.8; Control: 32.9±4.5 vs. 31.9±4.3), social aspects (IHT: 46.4±3.6 vs. 50.0±2.3; Control: 48.8±2.7 vs. 48.8±1.7), emotional problems (IHT: 85.7±8.4 vs. 92.9±5.2; Control: 79.4±7.8 vs. 71.4±6.6), mental health (IHT: 61.7±2.8 vs. 58.0±2.5; Control: 54.5±2.4 ± 55.6±1.9), and vitality (IHT: 60.0±4.3 vs. 58.6±4.0; Control: 50.7±2.9 vs. 53.6±3.0) after 12-weeks of supervised IHT (p&gt;0.05 for all). In conclusion, 12-weeks of IHT does not improve health-related quality of life in hypertensives. Therefore, in order to improve quality of life, other exercises should be an indicator for hypertensive patients.

Measuring the quality of life in hypertension according to Item Response Theory.

ABSTRACTOBJECTIVE To analyze the Miniquestionário de Qualidade de Vida em Hipertensão Arterial (MINICHAL – Mini-questionnaire of Quality of Life in Hypertension) using the Item Response Theory.METHODS This is an analytical study conducted with 712 persons with hypertension treated in thirteen primary health care units of Fortaleza, State of Ceará, Brazil, in 2015. The steps of the analysis by the Item Response Theory were: evaluation of dimensionality, estimation of parameters of items, and construction of scale. The study of dimensionality was carried out on the polychoric correlation matrix and confirmatory factor analysis. To estimate the item parameters, we used the Gradual Response Model of Samejima. The analyses were conducted using the free software R with the aid of psych and mirt.RESULTS The analysis has allowed the visualization of item parameters and their individual contributions in the measurement of the latent trait, generating more information and allowing the construction of a scale with an interpretative model that demonstrates the evolution of the worsening of the quality of life in five levels. Regarding the item parameters, the items related to the somatic state have had a good performance, as they have presented better power to discriminate individuals with worse quality of life. The items related to mental state have been those which contributed with less psychometric data in the MINICHAL.CONCLUSIONS We conclude that the instrument is suitable for the identification of the worsening of the quality of life in hypertension. The analysis of the MINICHAL using the Item Response Theory has allowed us to identify new sides of this instrument that have not yet been addressed in previous studies.

PP.16.13

Objective: Recent studies stress the importance of a magnesium deficiency being involved in the pathogenesis of essential hypertension, heart insufficiency or disorders in heart rhythm. The main pathophysiologic action of magnesium is being a calcium antagonist. In newer studies the blood pressure lowering and cardioprotective effect of a magnesium therapy has often been described. This effect is dose dependent and the supplementation time is of importance. Most studies describe a positive effect of about 300 mg magnesium daily, given 2–3 times orally. The MACH study showed a positive effect of magnesium on heart insufficiency concerning life quality and expectancy (p < 0.05). Therefore we studied hypertensives with heart insufficiency under an additional magnesium supplementation. Design and method: 11 hypertensives with heart insufficiency NYHA III-IV were investigated versus controls concerning magnesium status, kidney function, blood pressure and nTproBNP values before and after additional magnesium therapy. Magnesium orotate with organic magnesium of about 300 mg daily, 3 times were substituted orally in patients for 1 week. Results: The results showed in all magnesium treated hypertensive patients a positive effect on blood pressure, heart rhythm disorders and a lowering positive effect on nTproBNP values as a marker for heart insufficiency (p < 0.05). No side effects occur. Conclusions: The data presented here show a positive effect of a magnesium therapy on hypertension and hypertensive heart disease NYHA III-IV. In addition to genuine heart insufficiency therapy magnesium orotate improves nTproBNP values significantly and quality of life in hypertensives. In conclusion an intact magnesium status is of special importance in patients with essential hypertension suffering from hypertensive heart disease.

Health-related quality of life in hypertension: impact of a pharmacy intervention programme

In a previous study, we observed that a pharmacy-based intervention programme decreased the blood pressure of hypertensive patients. The objective of the present study was to assess the effect of this pharmacy programme on the health-related quality of life (HRQOL) of individuals treated for hypertension. In a quasi-experimental cohort pilot study, we recruited 91 participants from nine pharmacies in the Quebec City area. We offered the intervention programme over a 9-month period to participants enrolled at four of the pharmacies. The other participants were not exposed to pharmaceutical services other than those usually given by their pharmacists. We used the SF-36 to evaluate HRQOL. Covariance analysis was used to test for significant differences of HRQOL scores between participants exposed and not exposed to the programme. When compared with the non-exposed participants, those receiving the intervention and with high income had an improvement in vitality score (P=0.05). On the contrary, low-income exposed participants did not show this benefit and had a decline in mental health score (P=0.01). Improvement in vitality is likely due to increased physical activity and to a reduction in systolic blood pressure in the high-income exposed group. The negative effect of the programme on the mental health of those exposed in the low-income group might be due to the fact that the programme was not effective in reducing blood pressure and may therefore have caused anxiety. Pharmacists' interventions can have both a positive and negative impact on the HRQOL of individuals, treated with antihypertensive agents, depending on income level.

Relation between clinical and therapeutic variables and quality of life in hypertension

Study the relation between quality of life (QoL) and various clinical, therapeutic and sociodemographic variables in treated hypertensive patients. A prospective study was carried out in 92 primary care centres in Spain. A total of 269 hypertensive patients were selected and 106 healthy normotensive individuals were included as controls. At the time of inclusion a wide range of clinical variables was documented. QoL was assessed at baseline and 1 month after the intensification of antihypertensive therapy, using a self-administered, specific hypertension, 56-item questionnaire in addition to the generic EuroQoL-5D. QoL was poorer among the hypertensive subjects than among the normotensive individuals, even adjusting for the differences observed between the groups (age, sex, education and working status). The same was found with the EuroQol-5D. In the hypertensive subjects, after applying a multiple regression equation, only four variables significantly retained their negative impact on QoL: sex (female), greater organ damage and higher heart rate and weight. After the intensification of antihypertensive therapy with irbesartan, QoL improved significantly. Neither the presence of side-effects during the month of follow-up, nor the degree of BP reduction showed a significant impact on QoL, although the latter came close to statistical significance. Hypertensive patients have significantly poorer QoL than normotensive subjects, even with adjustment for differences. In hypertensives, QoL is affected by some clinical variables that might help us to identify those with worse QoL. Intensification of antihypertensive therapy produced a positive impact on QoL.

Compliance, quality of life, and cost effectiveness

Introduction Fewer than a half of people in the United States with high blood pressure are currently on treatment and of these less than half have their blood pressures controlled to less than 140/90 mm Hg [1]. Similar results have been found in New Zealand, Italy, and Spain [2–4] The limited success in controlling blood pressure stems from multiple factors including uncertainty of patients about the benefits of treatment for this silent disease, failures of patient compliance, adverse effects of medications, less than optimal efforts by physicians to encourage patients to adhere to regimens, and failures of the health-care system to reduce barriers to continued care. This article reviews recent studies on patient compliance and the measurement of the quality of life and then summarizes their implications for the cost-effectiveness of treatment for hypertension. Very few recent clinical trials have directly evaluated interventions to improve patien compliance or have directly examined the effects of treatment on the quality of life in hypertensives. Most available studies are retrospective and either observational or meta-analytic in nature.

Quality of life and cost-effectiveness in the treatment of hypertension.

By and large, the results of the different studies on quality of life in hypertension suggest that among beta-blockers only the nonselective beta-blocker propranolol has a negative effect on well-being, being associated with depression and side-effects. The findings on diuretics are comparatively few, and mainly observed as an adverse impact on sexual function. If one broadens the treatment scenario to include mortality and morbidity, evidence of a beneficial impact has only been proven for beta-blockers and diuretics. With the primary aim of antihypertensive drug therapy given as a reduction in cardiovascular risk factors, the aim with regard to quality of life is that quality of life be maintained. The new guidelines on the management of mild hypertension issued in the United States highlight the danger of relaxing the concern for risk reduction and costs in favour of surrogate end-points, even though these may carry great significance in the individual patient.

Quality of Life in Hypertension—The Effect of “Care” versus “Therapy”

This paper reports on a study which compared three antihypertensive treatments: cilazapril, atenolol, and nifedipine retard. Quality of life (QOL) assessments were made four times during the study. It was found that the care effect—the act of entering the study—had a large, consistent beneficial effect on patients' QOL. Treatment by comparison had little or no effect. The study demonstrated that having a run-in period is crucial to accurately attributing improvements in QOL.

Quality of life in hypertensives treated with atenolol or captopril: a double-blind crossover trial

To compare the effects of captopril and atenolol on quality of life of hypertensive patients. In a randomly allocated double-blind crossover trial with two 6-week treatment periods captopril at 25 mg twice a day or atenolol at 50 mg once a day were administered to 265 hypertensive patients (mean age 56 years; 55% men). Of these, 65% were newly treated hypertensives and 35% were previously uncontrolled on a diuretic alone. A seated diastolic blood pressure of 95-115 mmHg was required after a 3-week placebo run-in period. Any previous diuretic therapy was changed to hydrochlorothiazide (25 mg once a day) and the dose was kept constant throughout the trial. Newly diagnosed patients did not take a diuretic at any time. Quality of life was assessed from self-completed questionnaires measuring psychological well-being, symptomatic side effects of treatment, and activity and perceived well-being (a health index). A relative's perception of the patients' mood was also obtained where possible. Twelve patients withdrew on atenolol and 10 on captopril. No differences between the drugs were observed in quality of life measures, and 95% confidence intervals suggested that important differences were excluded. We conclude that at the doses used in this trial there were no important differences between captopril and atenolol in their effects on quality of life.

Cognitive Function and Quality of Life in Hypertension — A Community Based Study

Cognitive Function and Quality of Life in Hypertension — A Community Based Study